Role of IL-6 in the Pathogenesis of Yersinia enterocolitica infection
IL-6在小肠结肠炎耶尔森菌感染发病机制中的作用
基本信息
- 批准号:7429690
- 负责人:
- 金额:$ 35.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnti-Inflammatory AgentsAnti-inflammatoryAreaBackBacteriaBacterial InfectionsCellsChildChronicClinicalCommunicable DiseasesComplexDataDiseaseEtiologyFoodGastrointestinal DiseasesGoalsImmuneImmune responseImmune systemIn VitroInfectionInflammationInflammatoryInflammatory ResponseInflammatory disease of the intestineInterleukin-1Interleukin-6IntestinesKnowledgeLeadLearningMediatingMesenteryModelingMolecularMolecular ProfilingMorbidity - disease rateMusPasteurella pseudotuberculosisPathogenesisPathologyPlaguePlasmidsPlayRegulationResearch PersonnelResolutionRiskRoleSourceSpleenStagingStructure of aggregated lymphoid follicle of small intestineSyndromeT-LymphocyteTestingThinkingType III Secretion System PathwayVirulenceVirulence FactorsWaterYersiniaYersinia enterocoliticaYersinia infectionsanakinracytokineenteric pathogenfeedingin vivoinhibitor/antagonistinsightlymph nodesmortalityoral infectionpathogenpreventprogramsresponse
项目摘要
DESCRIPTION (provided by applicant): Food and water borne infectious diseases are a significant source of morbidity and mortality world-wide. Children are especially at risk from these infections. Although often assumed to be only a problem in developing areas of the world, bacterial infections of the gastro-intestinal tract remain a serious source of disease in the US. Our long-term goal is to understand both host-response and host pathogen interactions in the gut to Yersinia enterocolitica that lead to resolution of infection or to pathology. Y. enterocolitica is an excellent pathogen to use in our studies as it has served as one of the paradigms of bacterial infectious diseases. In this proposal we expand our studies to look at the role of IL-6 in the modulation of the host response during Y. enterocolitica infection. We hypothesize that IL-6 may be a crucial regulator of inflammatory responses to infection by influencing the cytokine response of host cells involved in response to Y. enterocolitica infection. We also hypothesize that the IL-6 mediated tempering of inflammatory responses may be triggered by Y. enterocolitica encoded molecules. To test these hypotheses we propose the following specific aims: 1) Identify the cells producing IL-6 in response to Y. enterocolitica infection and 2) the cells responding to IL-6 during infection in the Peyer's patch, mesenteric lymph node, and spleen. These data will give us insight into which host cells are modulating the host response to infection. 3) Test the contribution of the IL-6 modulated cytokines to the immunopathogenesis of intestinal yersiniosis. Mice deficient in IL-6 have distinct cytokine expression profiles and many of these cytokines are critical to the resolution of disease but it is unknown how mis-regulation of these cytokines contributes to pathology. These data will explore the connection between IL-6 mediated modulation of the immune response and Yersinia virulence. Altogether, these data will give us insight into how IL-6 contributes to the pathogenesis of Yersinia infection and how immune pathologies are prevented during self limiting infections. These data may provide insight into the etiology of chronic intestinal inflammation.
描述(申请人提供):食物和水传播的传染病是世界范围内发病率和死亡率的重要来源。儿童尤其容易受到这些感染。尽管通常被认为只是世界发展中地区的一个问题,但在美国,胃肠道细菌感染仍然是一个严重的疾病来源。我们的长期目标是了解肠道中宿主反应和宿主病原体的相互作用,从而导致感染的解决或病理。小肠结肠炎耶尔森氏菌是一种很好的病原体,在我们的研究中使用,因为它已经成为细菌感染性疾病的范例之一。在这项提案中,我们扩展了我们的研究,以观察IL-6在小肠结肠炎耶尔森菌感染过程中对宿主反应的调节作用。我们推测,IL-6可能通过影响宿主细胞对小肠结肠炎耶尔森菌感染的细胞因子反应而成为感染炎症反应的重要调节因子。我们还假设,IL-6介导的炎症反应的缓和可能是由小肠结肠炎耶尔森菌编码的分子触发的。为了验证这些假说,我们提出了以下具体目标:1)确定在小肠结肠炎耶尔氏菌感染时产生IL-6的细胞,以及2)在Peyer氏斑、肠系膜淋巴结和脾中感染时对IL-6做出反应的细胞。这些数据将使我们深入了解哪些宿主细胞正在调节宿主对感染的反应。3)检测IL-6调节的细胞因子在肠道耶尔森病免疫发病机制中的作用。IL-6缺乏的小鼠有不同的细胞因子表达谱,其中许多细胞因子对疾病的解决至关重要,但这些细胞因子的错误调节如何导致病理尚不清楚。这些数据将探索IL-6介导的免疫反应调节与耶尔森氏菌毒力之间的联系。总之,这些数据将使我们深入了解IL-6如何在耶尔森菌感染的发病机制中发挥作用,以及如何在自限性感染期间预防免疫病理。这些数据可能为慢性肠炎的病因提供洞察力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER H DUBE其他文献
PETER H DUBE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER H DUBE', 18)}}的其他基金
The role of CARDS toxin in genesis and exacerbation of allergic inflammation
CARDS毒素在过敏性炎症发生和恶化中的作用
- 批准号:
8181913 - 财政年份:2011
- 资助金额:
$ 35.81万 - 项目类别:
Role of IL-6 in the Pathogenesis of Yersinia enterocolitica infection
IL-6在小肠结肠炎耶尔森菌感染发病机制中的作用
- 批准号:
8071333 - 财政年份:2010
- 资助金额:
$ 35.81万 - 项目类别:
Role of CARDS Toxin in M. pneumoniae Associated Asthma in Mice
卡毒素在小鼠肺炎支原体相关哮喘中的作用
- 批准号:
7686472 - 财政年份:2008
- 资助金额:
$ 35.81万 - 项目类别:
Role of IL-6 in the Pathogenesis of Yersinia enterocolitica infection
IL-6在小肠结肠炎耶尔森菌感染发病机制中的作用
- 批准号:
7871363 - 财政年份:2007
- 资助金额:
$ 35.81万 - 项目类别:
Role of IL-6 in the Pathogenesis of Yersinia enterocolitica infection
IL-6在小肠结肠炎耶尔森菌感染发病机制中的作用
- 批准号:
7319055 - 财政年份:2007
- 资助金额:
$ 35.81万 - 项目类别:
Role of IL-6 in the Pathogenesis of Yersinia enterocolitica infection
IL-6在小肠结肠炎耶尔森菌感染发病机制中的作用
- 批准号:
8075459 - 财政年份:2007
- 资助金额:
$ 35.81万 - 项目类别:
Role of IL-6 in the Pathogenesis of Yersinia enterocolitica infection
IL-6在小肠结肠炎耶尔森菌感染发病机制中的作用
- 批准号:
7623116 - 财政年份:2007
- 资助金额:
$ 35.81万 - 项目类别:
Role of CARDS Toxin in M. pneumoniae Associated Asthma in Mice
卡毒素在小鼠肺炎支原体相关哮喘中的作用
- 批准号:
7150760 - 财政年份:2006
- 资助金额:
$ 35.81万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 35.81万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 35.81万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 35.81万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 35.81万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 35.81万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 35.81万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 35.81万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 35.81万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 35.81万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 35.81万 - 项目类别: